Do you or someone you know well been affected by rheumatoid arthritis? Your input is needed on a protocol considering dose reduction of non-TNF biologic and targeted synthetic disease-modifying anti-rheumatic drugs for people with rheumatoid arthritis in remission.
Skills / interests: Patient and public input
I am looking for a consumer who would be willing to provide feedback for a Cochrane protocol, “Dose reduction and discontinuation of non-TNF biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activity”. Cochrane considers a consumer to be a person with experience of the condition (in this case, rheumatoid arthritis), either as a patient or as a carer/family member of a patient.
A protocol is a plan for a systematic review. Consumer input at protocol stage is integral to ensure that the completed systematic review will be helpful to patients and carers with healthcare decision making. For consumer peer review, you will be asked to complete a short form with your feedback. Our aim is for this to be a manageable task, that does not overburden consumer reviewers.
Thank you in advance for considering!